2015 Speakers

FDA
Lawrence Yu
Acting Director
FDA
Norwegian Medicines Agency
Dr Øyvind Holte
Scientific Officer, EMA PAT Team
Norwegian Medicines Agency
Eli Lilly
Paul Desmond
QCL Consultant
Eli Lilly
Hovione
Nuno Matos
PAT Specialist
Hovione
FMC Health and Nutrition
Brian Carlin
Director of Open Innovation
FMC Health and Nutrition
Novartis
Jacques Wiss
Senior PAT Expert
Novartis
Bristol-Myers Squibb
Sushil Srivastava
Process Research and Development Director
Bristol-Myers Squibb
Lonza Group
Tobias Merz
PAT Team Lead
Lonza Group
H. Lundbeck A/S
Morten Alleso
QbD and PAT Specialist
H. Lundbeck A/S
Novo Nordisk
Michael Schousboe
Principal Specialist Quality Risk Management
Novo Nordisk
Novo Nordisk
Sune Klint Anderson
Principal Scientist
Novo Nordisk
Sanofi Pasteur
Baptiste Berruee
Statistical Analyst, Data Warehouse Project Leader
Sanofi Pasteur
Vertex Pharmaceuticals
Justin Pritchard
Senior Scientist
Vertex Pharmaceuticals
UCB Pharma
Edith Norrant
Innovations Technology Sciences Director
UCB Pharma
Medical Products Agency
Mats Welin
Senior Expert, EMA PAT Team
Medical Products Agency
GlaxoSmithKline
Melanie Dumarey
Chemometrician
GlaxoSmithKline
Novartis
Vishal Rosha
Principal Scientist BioProcess Research and Development
Novartis

Maximise Production Efficiency, Reduce Production Cycle Time, Reduce Cost and Increase Product Quality with PAT and Quality by Design

Join the likes of Novartis, GlaxoSmithKline, Novo Nordisk, Eli Lilly and Vertex Pharmaceuticals for a jam-packed three days of brand new case studies looking at the different applications of quality by design and PAT across both pharma and biotech.

Don’t miss out on this industry led event to share experiences, discuss challenges and develop best strategies to integrate quality by design and PAT and increase process control and understanding. Book now!

Unravel the regulatory requirements and participate in an open discussion with regulatory experts from the Norwegian Medicines Agency and Medical Products Agency and determine best practice for achieving a successful quality by design or PAT application first time around.

Hear directly from the FDA and explore their new approach to quality assessment and utilising process capability. Download the agenda here.

The PAT and Quality by Design Conference brings together industry leaders and is returning for its 12th year with brand new topics and a more discussion-based agenda to provide you with that extra time to network with peers, share challenges and problem solve together. Download the brochure and register for the event here!

P.S. Don't forget to take a look at our in-depth workshops on PAT applications and multi-variate data processing!

I am interested in:

Join us from 23rd to 25th March 2015 in London to:

  • Deconstruct QbD and PAT regulatory requirements with the Norwegian Medicines Agency
  • Increase product quality with real examples of on-line monitoring with Novartis and Hovione
  • Effectively manage and analyse continuous data with GSK, Novartis and Sanofi Pasteur
  • Develop a sound process control strategy with Bristol-Myers Squibb
  • Transition to continuous manufacturing with Vertex Pharmaceuticals and Eli Lilly

Media Partners

Download 2015 Agenda

Resource Centre

Visit the Resource Center for complimentary industry related content!

Featured Content

Sponsorship Opportunity

Learn more about sponsor & exhibit opportunities

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!

Quick Links